Waterley Pharmaceuticals Private Limited, a active private limited company, was established on 07 February 2014 in Secunderabad, Telangana, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24232TG2014PTC092812. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹4.00 M and a paid-up capital of ₹3.72 M.
It upholds a compliant status. Employing 83 professional, Its leadership includes Ganesh Kumar Kappagantu (Director), Megamreddy Balling (Director), Venu Gopal Reddy Repally Senagapally (Director). Past directors included Bathula Vijaya. It holds ₹4.86 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H No. 9-7-211/23-24, 1St Floor, Swargam Arcade, Green View Enclave, Phase - I, Hasmathpe, T,, Secunderabad, Telangana, 500009.
U24232TG2014PTC092812
092812
07 February 2014
₹4.00 M
₹3.72 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Waterley Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ganesh Kumar Kappagantu | Director | 29 Jan 2020 | Current |
| Megamreddy Balling | Director | 25 Sep 2017 | Current |
| Venu Gopal Reddy Repally Senagapally | Director | 07 Feb 2014 | Current |
| Manish Kumar Sutrave | Director | 07 Feb 2014 | Current |
| Shinod Karrayi Parreri | Director | 07 Feb 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Sep 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Waterley Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 76.36% increase. The company also saw a substantial improvement in profitability, with a 159.46% increase in profit. The company's net worth Soared by an impressive increase of 95.58%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Waterley Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹48,591,052.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Feb 2025 | Hdfc Bank Limited | ₹3.65 M | Open |
| 27 Feb 2025 | Hdfc Bank Limited | ₹3.65 M | Open |
| 27 Jan 2025 | Hdfc Bank Limited | ₹3.65 M | Open |
| 04 Jan 2025 | Hdfc Bank Limited | ₹3.65 M | Open |
| 30 Oct 2024 | Others | ₹4.00 M | Open |
Explore comprehensive loan charge details -
Waterley Pharmaceuticals has a workforce of 83 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Waterley Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Waterley Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 3.65 M with Charge ID 101061536 was registered on 27 Feb 2025. was documented.
A charge with Hdfc Bank Limited amounted to Rs. 3.65 M with Charge ID 101061535 was registered on 27 Feb 2025. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 3.65 M with Charge ID 101040897 was registered on 27 Jan 2025. was documented.
The activity A charge with Hdfc Bank Limited amounted to Rs. 3.65 M with Charge ID 101041845 was registered on 04 Jan 2025. was completed.
The activity A charge with Others amounted to Rs. 4.00 M with Charge ID 101042446 was registered on 30 Oct 2024. was completed.
The activity Waterley Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The CIN of Waterley Pharmaceuticals Private Limited is U24232TG2014PTC092812.
Waterley Pharmaceuticals Private Limited is headquartered at H No. 9-7-211/23-24, 1St Floor, Swargam Arcade, Green View Enclave, Phase - I, Hasmathpe, T,, Secunderabad, Telangana, 500009.
Waterley Pharmaceuticals Private Limited was incorporated on 07 February 2014.
The current directors of Waterley Pharmaceuticals Private Limited are
The primary industry of Waterley Pharmaceuticals Private Limited is Trade.
Waterley Pharmaceuticals Private Limited is unlisted.
The authorized capital of Waterley Pharmaceuticals Private Limited is ₹4.00 M, and the paid-up capital is ₹3.72 M.
The compliance status of Waterley Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX